Zhu Cheng, Zhang Han, Shen Ziyan, Chen Jing, Gu Yulu, Lv Shiqi, Li Yang, Zhu Bowen, Ding Xiaoqiang, Zhang Xiaoyan
Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Clin Kidney J. 2022 Mar 7;15(7):1322-1332. doi: 10.1093/ckj/sfac070. eCollection 2022 Jul.
The decline in estimated glomerular filtration rate (eGFR) has been reported as a risk factor for mortality. However, it remains unclear which eGFR equation is most useful in predicting death in the general Chinese population.
The association was examined between eGFR and all-cause mortality using data from the China Health and Retirement Longitudinal Study. Participants with complete data in 2011 and survival follow-up in 2013, 2015 and 2018 were included and analyzed in three separate cohorts, which included 8160, 8154 and 8020 participants, respectively. Logistic regression analyses, receiver operating characteristic curve, continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were computed to compare the discriminative power of eGFR derived by abbreviated Modification of Diet in Renal Disease (MDRD), Chinese coefficient-modified MDRD (MDRD-CN), Japanese coefficient-modified MDRD (MDRD-JPN), CKD-EPI, Japanese coefficient-modified CKD-EPI (CKD-EPI-JPN), CKD-EPI, CKD-EPI, CKD-EPI fit without race and CKD-EPI fit without race.
A decreased eGFR (<60 ml/min/1.73 m) was significantly associated with increased mortality at 2 years no matter which eGFR equation was used (odds ratio ranged between 2.02 and 4.94, all P < 0.001). The association remained significant after adjusting multiple covariates when MDRD-CN, CKD-EPI or CKD-EPI fit without race was used. CKD-EPI showed the highest discriminative power for mortality (area under the curve 0.744 ± 0.40) and outperformed other equations (all P < 0.001) except for CKD-EPI. The overall risk classification was also improved when the CKD-EPI equation was adopted as indicated by continuous NRI and IDI. Similar results were observed at 4 and 7 years.
A decline in eGFR by all equations could predict poorer survival, among which the CKD-EPI equation showed the best discriminative power.
估算肾小球滤过率(eGFR)下降已被报道为死亡的危险因素。然而,尚不清楚哪种eGFR方程在预测中国普通人群的死亡方面最有用。
利用中国健康与养老追踪调查的数据,研究eGFR与全因死亡率之间的关联。纳入2011年有完整数据且在2013年、2015年和2018年有生存随访的参与者,并分别在三个独立队列中进行分析,各队列分别包括8160名、8154名和8020名参与者。计算逻辑回归分析、受试者工作特征曲线、连续净重新分类改善(NRI)和综合判别改善(IDI),以比较由简化的肾脏病饮食改良(MDRD)、中国系数修正的MDRD(MDRD-CN)、日本系数修正的MDRD(MDRD-JPN)、慢性肾脏病流行病学协作组(CKD-EPI)、日本系数修正的CKD-EPI(CKD-EPI-JPN)、CKD-EPI、无种族因素的CKD-EPI拟合、无种族因素的CKD-EPI拟合得出的eGFR的判别能力。
无论使用哪种eGFR方程,eGFR降低(<60 ml/min/1.73 m²)均与2年时死亡率增加显著相关(比值比在2.02至4.94之间,所有P<0.001)。当使用MDRD-CN、CKD-EPI或无种族因素的CKD-EPI拟合调整多个协变量后,该关联仍然显著。CKD-EPI对死亡率的判别能力最高(曲线下面积为0.744±0.040),除CKD-EPI外,其表现均优于其他方程(所有P<0.001)。如连续NRI和IDI所示,采用CKD-EPI方程时总体风险分类也得到改善。在4年和7年时观察到类似结果。
所有方程得出的eGFR下降均能预测较差的生存率,其中CKD-EPI方程的判别能力最佳。